EXPLORing exosomes for the treatment of acute kidney injury
- PMID: 34420658
- DOI: 10.1016/j.kint.2021.05.039
EXPLORing exosomes for the treatment of acute kidney injury
Abstract
Exosomes are emerging as a novel drug delivery system for the treatment of numerous diseases, including acute kidney injury. In this issue of Kidney International, Kim et al. use a novel optogenetically engineered exosome technology, "EXPLOR," to deliver the exosomal repressor of nuclear factor-κB into mice before and after renal ischemia-reperfusion. They report that these exosomes downregulated renal nuclear factor-κB signaling and ameliorated acute kidney injury. This study deserves attention for its significant scientific and potential clinical value in acute kidney injury.
Copyright © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Comment on
- 
  
  Exosome-based delivery of super-repressor IκBα ameliorates kidney ischemia-reperfusion injury.Kidney Int. 2021 Sep;100(3):570-584. doi: 10.1016/j.kint.2021.04.039. Epub 2021 May 27. Kidney Int. 2021. PMID: 34051264
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
 
        